Related Experiment Video

Updated: Nov 15, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.1K

Vaccine fails to prevent chronic HCV infection

Katrina Ray1

  • 1Nature Reviews Gastroenterology & Hepatology, . nrgasthep@nature.com.

Nature Reviews. Gastroenterology & Hepatology
|March 3, 2021
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

11.8K
A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.5K

Related Experiment Videos

Last Updated: Nov 15, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

7.1K
Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

11.8K
A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.5K

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

48.3K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
48.3K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

97
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
97

Articles linked to this work by shared authors, journal, and citation graph.

Sexual dimorphism in the liver.

Nature reviews. Gastroenterology & hepatology·2026

Global epidemiology of metabolic and alcohol-associated liver disease: risk factors, natural history and clinical implications.

Nature reviews. Gastroenterology & hepatology·2026

The dynamic spectrum of steatotic liver disease: the global perspective.

Nature reviews. Gastroenterology & hepatology·2026

Multidisciplinary Delphi consensus statement on minimal standards for clinical metadata and end points in microbiome studies.

Nature reviews. Gastroenterology & hepatology·2026

Mechanisms, management and prevention of anorectal sexually transmitted infections.

Nature reviews. Gastroenterology & hepatology·2026

Conceptual framework and expert guidance on intrapancreatic fat deposition: the Melbourne consensus.

Nature reviews. Gastroenterology & hepatology·2026

AVF Occlusion Unveils True Hemodynamics: When the Shunt Matters.

JACC. Case reports·2026

Catheter-Directed Thrombolysis in Intermediate-High-Risk Pulmonary Embolism.

The New England journal of medicine·2026

Retrospective Cohort Study Assessing Remdesivir Effectiveness in Hospitalized COVID-19 Patients With Renal or Hepatic Comorbidities.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Comprehensive Viral Detection and Profiling of Plasma Cell-Free RNA in Patients With Suspected Hemophagocytic Lymphohistiocytosis.

Journal of medical virology·2026

Haemodynamic effects of selective venoconstriction with centhaquine in spontaneously breathing patients with mixed hypovolaemic-vasodilatory shock.

Experimental physiology·2026

The association of hypoxia-inducible factor-1 alpha expression, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio with three-year progression-free survival in locally advanced colorectal cancer patients.

Folia medica·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us